Search Results - "Nance, Melonie A"

Racial Diversity Among American Cardiologists: Implications for the Past, Present, and Future by Johnson, Amber E., Talabi, Mehret Birru, Bonifacino, Eliana, Culyba, Alison J., Davis, Esa M., Davis, Paula K., De Castro, Laura M., Essien, Utibe R., Maria Gonzaga, Alda, Hogan, MaCalus V., James, Alaina J., Jonassaint, Charles R., Jonassaint, Naudia L., Matheo, Loreta, Nance, Melonie A., Napoé, G. Sarah, Olafiranye, Oladipupo, Owusu-Ansah, Sylvia, Pierson-Brown, Tomar N., Conrad Smith, A.J., Suber, Tomeka L., Torres, Orquidia, Tripp, Rickquel, Ufomata, Eloho, Wilson, J. Deanna, South-Paul, Jeannette E.

“…In the United States, race-based disparities in cardiovascular disease care have proven to be pervasive, deadly, and expensive. African American/Black,…”
Get full text

Considerations for Racial Diversity in the Cardiology Workforce in the United States of America by Johnson, Amber E., Birru Talabi, Mehret, Bonifacino, Eliana, Culyba, Alison J., Jonassaint, Naudia L., Nance, Melonie A., Napoé, G. Sarah, Olafiranye, Oladipupo, Owusu-Ansah, Sylvia, Suber, Tomeka L.

Get full text

Leadership of Black Women Faculty in Otolaryngology—More than A Rounding Error by Flanary, Valerie, Jefferson, Gina D., Brown, David J., Arosarena, Oneida A., Brenner, Michael J., Cabrera‐Muffly, Cristina, Cannon, Trinitia Y., Faucett, Erynne A., Francis, Carrie L., Harvey, Erin, Johnson, Romaine F., Loyo, Myriam, Nance, Melonie A., Vinson, Kimberly N., Thompson, Dana M.

Get full text

Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit by Mascarella, Marco A, Olonisakin, Tolani F, Rumde, Purva, Vendra, Varun, Nance, Melonie A, Kim, Seungwon, Kubik, Mark W, Sridharan, Shaum S, Ferris, Robert L, Fenton, Moon J, Clayburgh, Daniel R, Ohr, James P, Joyce, Sonali C, Sen, Malabika, Herman, James G, Grandis, Jennifer R, Zandberg, Dan P, Duvvuri, Umamaheswar

“…Neoadjuvant targeted therapy provides a brief, preoperative window of opportunity that can be exploited to individualize cancer care based on treatment…”
Get full text

Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma by Nance, Melonie A., Seethala, Raja R., Wang, Yun, Chiosea, Simion I., Myers, Eugene N., Johnson, Jonas T., Lai, Stephen Y.

“…BACKGROUND. Histopathologic grade of mucoepidermoid carcinoma (MEC) is an established predictor of prognosis and affects treatment protocol. Tumor behavior is…”
Get full text

Characteristics of participants in a free oral, head and neck cancer screening program by Gourin, Christine G., Kaboli, Kavon C., Blume, Erin J., Nance, Melonie A., Koch, Wayne M.

“…Objective: Early detection of head and neck cancer is associated with improved survival. It is unclear if screening programs successfully target high‐risk…”
Get full text

Molecular (SNP) analyses of overlapping hemizygous deletions of 10q25.3 to 10qter in four patients: Evidence for HMX2 and HMX3 as candidate genes in hearing and vestibular function by Miller, Nathaniel D., Nance, Melonie A., Wohler, Elizabeth S., Hoover-Fong, Julie E., Lisi, Emily, Thomas, George H., Pevsner, Jonathan

“…We report on the analyses of four unrelated patients with de novo, overlapping, hemizygous deletions of the long arm of chromosome 10. These include two small…”
Get full text

The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment by Hardaker, Elizabeth L., Sanseviero, Emilio, Karmokar, Ankur, Taylor, Devon, Milo, Marta, Michaloglou, Chrysis, Hughes, Adina, Mai, Mimi, King, Matthew, Solanki, Anisha, Magiera, Lukasz, Miragaia, Ricardo, Kar, Gozde, Standifer, Nathan, Surace, Michael, Gill, Shaan, Peter, Alison, Talbot, Sara, Tohumeken, Sehmus, Fryer, Henderson, Mostafa, Ali, Mulgrew, Kathy, Lam, Carolyn, Hoffmann, Scott, Sutton, Daniel, Carnevalli, Larissa, Calero-Nieto, Fernando J., Jones, Gemma N., Pierce, Andrew J., Wilson, Zena, Campbell, David, Nyoni, Lynet, Martins, Carla P., Baker, Tamara, Serrano de Almeida, Gilberto, Ramlaoui, Zainab, Bidar, Abdel, Phillips, Benjamin, Boland, Joseph, Iyer, Sonia, Barrett, J. Carl, Loembé, Arsene-Bienvenu, Fuchs, Serge Y., Duvvuri, Umamaheswar, Lou, Pei-Jen, Nance, Melonie A., Gomez Roca, Carlos Alberto, Cadogan, Elaine, Critichlow, Susan E., Fawell, Steven, Cobbold, Mark, Dean, Emma, Valge-Archer, Viia, Lau, Alan, Gabrilovich, Dmitry I., Barry, Simon T.

“…The Ataxia telangiectasia and Rad3-related (ATR) inhibitor ceralasertib in combination with the PD-L1 antibody durvalumab demonstrated encouraging clinical…”
Get full text

Abstract CT198: Immunomodulatory effects of the ATR inhibitor ceralasertib in a window of opportunity biomarker trial in patients with head and neck squamous cell carcinoma by Jones, Gemma N., Iyer, Sonia, Milo, Marta, Lou, Pei-Jen, Nance, Melonie A., Gomez-Roca, Carlos A., Standifer, Nathan, Marco-Casanova, Paola, Gill, Shaan, Surace, Michael, Bystry, Richard, Alexandrova, Maria, Willis, Sophie, Rodriguez-Canales, Jaime, Dannhorn, Andreas, Loembé, Bienvenu, Lau, Alan, Lukashchuk, Natalia, Harrington, Elizabeth A., Sanai, Elhan, Dean, Emma, Duvvuri, Umamaheswar

“…Abstract Head and neck squamous cell carcinoma (HNSCC) is frequently locally advanced, but has a high risk of recurrence after initial treatment. Immune…”
Get full text

Characteristics of Participants in a Free Oral, Head and Neck Cancer Screening Program by Gourin, Christine G., Nance, Melonie A., Kaboli, Kavon C., Blume, Erin J., Koch, Wayne M.

Get full text